Interleukin-6 level is an independent predictor of right ventricular systolic dysfunction in patients hospitalized with COVID-19

• Published in: Anatolian journal of cardiology 2021-08, Vol.25 (8), p.555-564
• Main Authors: Erdoğan, Mehmet, Kaya Kalem, Ayşe, Öztürk, Selçuk, Erdöl, Mehmet Akif, Kayaaslan, Bircan, Özbebek, Yunus Emre, Güner, Rahmet
• Format: Article
• Language: English
• Subjects: Adult; COVID-19 - complications; COVID-19 - diagnostic imaging; COVID-19 - physiopathology; Echocardiography; Echocardiography, Doppler; Female; Hospitalization; Humans; Interleukin-6 - metabolism; Male; Middle Aged; Original Investigation; Prospective Studies; Tomography, X-Ray Computed; Ventricular Dysfunction, Right - etiology; Ventricular Dysfunction, Right - immunology
• ISSN: 2149-2263; 2149-2271
• DOI: 10.5152/AnatolJCardiol.2021.24946

Cytokine storm with elevated levels of multiple proinflammatory cytokines and inflammatory system activation underlie the pathogenesis of coronavirus disease 2019 (COVID-19). In this study, we aimed to investigate whether increased interleukin (IL)-6 levels can predict right ventricular (RV) systolic impairment in patients hospitalized with COVID-19. This prospective, observational study included 100 consecutive patients hospitalized with mild and moderate COVID-19. All the patients underwent chest computerized tomography, detailed laboratory tests including IL-6, and two dimensional (2D) transthoracic echocardiography (TTE) with assessment of 2D conventional and Doppler echocardiography parameters and RV systolic functions. After the elimination of six patients with exclusion criteria, the remaining patients were classified into two groups, namely normal RV systolic functions (n=60) and impaired RV systolic functions (n=34). IL-6 levels were significantly higher in patients with impaired RV systolic functions than in those with normal RV systolic functions (20.3, 4.6, p